Search research articles
Contact Us
Filters
Showing results (821-830 of 992) with videos related to
Page
of 100
Sort By:
British Journal of Haematology
|
December 2, 2017
Prospective subgroup analyses of the randomized MCL-002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma
Luca Arcaini, Thierry Lamy, Jan Walewski, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 8, 2018
Magnetically driven drug delivery systems improving targeted immunotherapy for colon-rectal cancer
Renata Grifantini, Monia Taranta, Lisa Gherardini, et al.
Virchows Archiv : an International Journal of Pathology
|
October 31, 2019
Correction to: A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit
Arianna Di Napoli, D Remotti, C Agostinelli, et al.
Oncotarget
|
September 17, 2016
The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma
Alessandra Romano, Nunziatina Laura Parrinello, Calogero Vetro, et al.
The Journal of Pathology
|
October 16, 2007
Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma
S Tedoldi, A Mottok, J Ying, et al.
Virchows Archiv : an International Journal of Pathology
|
August 29, 2018
Granulysin, a novel marker for extranodal NK/T cell lymphoma, nasal type
Giuseppe Lo Bello, Ayse U Akarca, Maria Raffaella Ambrosio, et al.
Blood
|
September 8, 2012
Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion
Claudio Tripodo, Sabina Sangaletti, Carla Guarnotta, et al.
Vaccine
|
July 13, 2010
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults
Sharon E Frey, Michael Houghton, Stephen Coates, et al.
Blood
|
January 5, 2002
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies
Paolo Corradini, Corrado Tarella, Attilio Olivieri, et al.
Iscience
|
October 21, 2020
A Spatially Resolved Dark- versus Light-Zone Microenvironment Signature Subdivides Germinal Center-Related Aggressive B Cell Lymphomas
Claudio Tripodo, Federica Zanardi, Fabio Iannelli, et al.
Page
of 100
Search research articles
Search
Showing results (821-830 of 992) with videos related to
Sort By:
Page
of 100
British Journal of Haematology
|
December 2, 2017
Prospective subgroup analyses of the randomized MCL-002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma
Luca Arcaini, Thierry Lamy, Jan Walewski, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 8, 2018
Magnetically driven drug delivery systems improving targeted immunotherapy for colon-rectal cancer
Renata Grifantini, Monia Taranta, Lisa Gherardini, et al.
Virchows Archiv : an International Journal of Pathology
|
October 31, 2019
Correction to: A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit
Arianna Di Napoli, D Remotti, C Agostinelli, et al.
Oncotarget
|
September 17, 2016
The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma
Alessandra Romano, Nunziatina Laura Parrinello, Calogero Vetro, et al.
The Journal of Pathology
|
October 16, 2007
Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma
S Tedoldi, A Mottok, J Ying, et al.
Virchows Archiv : an International Journal of Pathology
|
August 29, 2018
Granulysin, a novel marker for extranodal NK/T cell lymphoma, nasal type
Giuseppe Lo Bello, Ayse U Akarca, Maria Raffaella Ambrosio, et al.
Blood
|
September 8, 2012
Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion
Claudio Tripodo, Sabina Sangaletti, Carla Guarnotta, et al.
Vaccine
|
July 13, 2010
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults
Sharon E Frey, Michael Houghton, Stephen Coates, et al.
Blood
|
January 5, 2002
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies
Paolo Corradini, Corrado Tarella, Attilio Olivieri, et al.
Iscience
|
October 21, 2020
A Spatially Resolved Dark- versus Light-Zone Microenvironment Signature Subdivides Germinal Center-Related Aggressive B Cell Lymphomas
Claudio Tripodo, Federica Zanardi, Fabio Iannelli, et al.
Page
of 100